Fundraising FoxNFANT Labs
Port Richey, US · Founded 2023 · Delaware corporation
Find your way into NFANT Labs
Sign up to see every warm intro you have to NFANT Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NFANT Labs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
GC
Gilson CapiloutoNamed on SEC filing
TC
Tommy CunninghamNamed on SEC filing
LF
Louis. F. Malice, Jr.Named on SEC filing
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 5 rounds · 2018–2025
▶$50KraisedJul 2025 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedJul 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gilson CapiloutoDirector
- Tommy CunninghamExecutive Officer, Director
- Louis F. Malice, Jr.Executive Officer, Director
- Offering amount
- $690K
- Amount sold
- $50K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$530.3KraisedMay 2024 · 8 investors · Other Health CareRule 506(b)
▶$530.3KraisedMay 2024 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Louis F. Malice, Jr.Executive Officer, Director
- Gilson CapiloutoDirector
- Tommy CunninghamExecutive Officer, Director
- Offering amount
- $530.3K
- Amount sold
- $530.3K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$300KraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$300KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tommy CunninghamExecutive Officer, Director
- Gilson CapiloutoDirector
- Louis F. Malice, Jr.Executive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1.4MraisedMar 2023 · 17 investors · Other Health CareRule 506(b)
▶$1.4MraisedMar 2023 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tommy CunninghamExecutive Officer, Director
- Terri KlineDirector
- Louis F. Malice, Jr.Director
- Gilson CapiloutoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$612.5KraisedJun 2018 · 8 investors · Other Health CareRule 506(b)
▶$612.5KraisedJun 2018 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Louis. F. Malice, Jr.Executive Officer, Director
- Gilson CapiloutoExecutive Officer, Director
- Thomas Labs CunninghamExecutive Officer, Director
- Offering amount
- $632.5K
- Amount sold
- $612.5K
- Minimum investment
- $10K
- Proceeds to insiders
- $200K
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NFANT Labs raised?
- NFANT Labs has disclosed $2.9M raised across 5 rounds.
- Where is NFANT Labs headquartered?
- NFANT Labs is headquartered in Port Richey, US.